Sector Chart GT Biopharma, Inc.

Equities

GTBP

US36254L3087

Market Closed - Nasdaq 21:00:00 26/06/2024 BST 5-day change 1st Jan Change
3.035 USD +2.88% Intraday chart for GT Biopharma, Inc. +1.51% -60.33%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
6.55M - - - - -
811B
640B
353B - - - -
333B
302B